Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000722830-20-000023
Filing Date
2020-08-05
Accepted
2020-08-05 16:02:55
Documents
67
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q immu-20200630.htm   iXBRL 10-Q 1837824
2 EX-10.49 immu202010q630ex1049.htm EX-10.49 103810
3 EX-10.50 immu202010q630ex1050.htm EX-10.50 95911
4 EX-10.51 immu202010q630ex1051.htm EX-10.51 93737
5 EX-10.52 immu202010q630ex1052.htm EX-10.52 81960
6 EX-31.1 immu-6302020ex311.htm EX-31.1 10639
7 EX-32.1 immu-6302020ex321.htm EX-32.1 8690
  Complete submission text file 0000722830-20-000023.txt   6835421

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT immu-20200630.xsd EX-101.SCH 38117
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT immu-20200630_cal.xml EX-101.CAL 68009
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT immu-20200630_def.xml EX-101.DEF 215468
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT immu-20200630_lab.xml EX-101.LAB 490199
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT immu-20200630_pre.xml EX-101.PRE 323850
13 EXTRACTED XBRL INSTANCE DOCUMENT immu-20200630_htm.xml XML 947516
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 201077167
SIC: 2835 In Vitro & In Vivo Diagnostic Substances